Adult-type non-rhabdomyosarcoma soft tissue sarcomas in pediatric age: Salvage rates and prognostic factors after relapse
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adult-type non-rhabdomyosarcoma soft tissue sarcomas in pediatric age: Salvage rates and prognostic factors after relapse
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 169, Issue -, Pages 179-187
Publisher
Elsevier BV
Online
2022-05-14
DOI
10.1016/j.ejca.2022.03.037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Controversies and challenges in the management of paediatric non-rhabdomyosarcoma soft tissue sarcomas
- (2022) Andrea Ferrari et al. Lancet Child & Adolescent Health
- The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium
- (2022) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)
- (2021) Andrea Ferrari et al. Lancet Child & Adolescent Health
- A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
- (2019) Sheri L Spunt et al. LANCET ONCOLOGY
- The challenge of the management of adolescents and young adults with soft tissue sarcomas
- (2018) Andrea Ferrari et al. PEDIATRIC BLOOD & CANCER
- Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts
- (2017) Winette T A van der Graaf et al. LANCET ONCOLOGY
- Salvage rates and prognostic factors after relapse in children and adolescents with malignant peripheral nerve sheath tumors
- (2017) Luca Bergamaschi et al. PEDIATRIC BLOOD & CANCER
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
- (2016) Patrick Schöffski et al. LANCET
- Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
- (2014) A. Ferrari et al. ANNALS OF ONCOLOGY
- Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma
- (2012) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database
- (2011) Andrea Ferrari et al. PEDIATRIC BLOOD & CANCER
- Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groups
- (2010) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: Feasibility and efficacy in refractory pediatric sarcoma
- (2010) Cristina Meazza et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started